Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 440

1.

The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease.

Picillo M, Palladino R, Barone P, Erro R, Colosimo C, Marconi R, Morgante L, Antonini A; PRIAMO Study Group..

Eur J Neurol. 2017 Apr 20. doi: 10.1111/ene.13290. [Epub ahead of print]

PMID:
28425642
2.

Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease.

Caminiti SP, Presotto L, Baroncini D, Garibotto V, Moresco RM, Gianolli L, Volonté MA, Antonini A, Perani D.

Neuroimage Clin. 2017 Mar 27;14:734-740. doi: 10.1016/j.nicl.2017.03.011. eCollection 2017.

3.

Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.

Fabbri M, Coelho M, Guedes LC, Chendo I, Sousa C, Rosa MM, Abreu D, Costa N, Godinho C, Antonini A, Ferreira JJ.

Parkinsonism Relat Disord. 2017 Feb 7. pii: S1353-8020(17)30041-X. doi: 10.1016/j.parkreldis.2017.02.007. [Epub ahead of print]

PMID:
28389156
4.

The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.

Lehericy S, Vaillancourt DE, Seppi K, Monchi O, Rektorova I, Antonini A, McKeown MJ, Masellis M, Berg D, Rowe JB, Lewis SJG, Williams-Gray CH, Tessitore A, Siebner HR; International Parkinson and Movement Disorder Society (IPMDS)-Neuroimaging Study Group..

Mov Disord. 2017 Apr;32(4):510-525. doi: 10.1002/mds.26968. Epub 2017 Mar 28. Review.

PMID:
28370449
5.

ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.

Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P.

J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):317-324. doi: 10.1136/jnnp-2016-315277.

PMID:
28315845
6.

Tremor UPDRS estimation in home environment.

Rigas G, Gatsios D, Fotiadis DI, Chondrogiorgi M, Tsironis C, Konitsiotis S, Gentile G, Marcante A, Antonini A.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3642-3645. doi: 10.1109/EMBC.2016.7591517.

PMID:
28269083
7.

Monitoring of motor and non-motor symptoms of Parkinson's disease through a mHealth platform.

Cancela J, Villanueva Mascato S, Gatsios D, Rigas G, Marcante A, Gentile G, Biundo R, Giglio M, Chondrogiorgi M, Vilzmann R, Konitsiotis S, Antonini A, Arredondo MT, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:663-666. doi: 10.1109/EMBC.2016.7590789.

PMID:
28268415
8.

Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up.

Sensi M, Cossu G, Mancini F, Pilleri M, Zibetti M, Modugno N, Quatrale R, Tamma F, Antonini A; ITALIAN LEVODOPA CARBIDOPA INTESTINAL GEL WORKING GROUP..

Parkinsonism Relat Disord. 2017 May;38:90-92. doi: 10.1016/j.parkreldis.2017.02.020. Epub 2017 Feb 21.

PMID:
28238650
9.

Staging and follow-up of cutaneous melanoma patients.

Gutiérrez García-Rodrigo C, Antonini A, Rocco T, Pellegrini C, Micantonio T, Fargnoli MC.

G Ital Dermatol Venereol. 2017 Jun;152(3):231-240. doi: 10.23736/S0392-0488.17.05581-X. Epub 2017 Feb 14.

PMID:
28195451
10.

Characterization of melanoma susceptibility genes in high-risk patients from Central Italy.

Pellegrini C, Maturo MG, Martorelli C, Suppa M, Antonini A, Kostaki D, Verna L, Landi MT, Peris K, Fargnoli MC.

Melanoma Res. 2017 Jan 31. doi: 10.1097/CMR.0000000000000323. [Epub ahead of print]

PMID:
28146043
11.

Oxidative Stress-Induced miR-200c Disrupts the Regulatory Loop Among SIRT1, FOXO1, and eNOS.

Carlomosti F, D'Agostino M, Beji S, Torcinaro A, Rizzi R, Zaccagnini G, Maimone B, Di Stefano V, De Santa F, Cordisco S, Antonini A, Ciarapica R, Dellambra E, Martelli F, Avitabile D, Capogrossi MC, Magenta A.

Antioxid Redox Signal. 2017 Jan 19. doi: 10.1089/ars.2016.6643. [Epub ahead of print]

PMID:
27960536
12.

Scanless functional imaging of hippocampal networks using patterned two-photon illumination through GRIN lenses.

Moretti C, Antonini A, Bovetti S, Liberale C, Fellin T.

Biomed Opt Express. 2016 Sep 12;7(10):3958-3967. eCollection 2016 Oct 1.

13.

Targeting of the Subthalamic Nucleus for Deep Brain Stimulation: A Survey Among Parkinson Disease Specialists.

Hamel W, Köppen JA, Alesch F, Antonini A, Barcia JA, Bergman H, Chabardes S, Contarino MF, Cornu P, Demmel W, Deuschl G, Fasano A, Kühn AA, Limousin P, McIntyre CC, Mehdorn HM, Pilleri M, Pollak P, Rodríguez-Oroz MC, Rumià J, Samuel M, Timmermann L, Valldeoriola F, Vesper J, Visser-Vandewalle V, Volkmann J, Lozano AM.

World Neurosurg. 2017 Mar;99:41-46. doi: 10.1016/j.wneu.2016.11.012. Epub 2016 Nov 9.

PMID:
27838430
14.

Dopaminergic Medication Modulates Learning from Feedback and Error-Related Negativity in Parkinson's Disease: A Pilot Study.

Volpato C, Schiff S, Facchini S, Silvoni S, Cavinato M, Piccione F, Antonini A, Birbaumer N.

Front Behav Neurosci. 2016 Oct 24;10:205. eCollection 2016.

15.

Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review.

de Cuba CM, Albanese A, Antonini A, Cossu G, Deuschl G, Eleopra R, Galati A, Hoffmann CF, Knudsen K, Landi A, Lanotte MM, Marcante A, Mosch A, Pilleri M, Reich MM, Ricchi V, Rinaldo S, Romito LM, Saba FS, Sacristan HE, Schuurman PR, Trezza A, van den Munckhof P, Volkmann J, Zibetti M, Contarino MF.

Parkinsonism Relat Disord. 2016 Nov;32:108-115. doi: 10.1016/j.parkreldis.2016.09.007. Epub 2016 Sep 6.

PMID:
27622967
16.

Brain structural profile of multiple system atrophy patients with cognitive impairment.

Fiorenzato E, Weis L, Seppi K, Onofrj M, Cortelli P, Zanigni S, Tonon C, Kaufmann H, Shepherd TM, Poewe W, Krismer F, Wenning G, Antonini A, Biundo R; Movement Disorders Society MSA (MODIMSA) Neuropsychology and Imaging Study Groups..

J Neural Transm (Vienna). 2017 Mar;124(3):293-302. doi: 10.1007/s00702-016-1636-0. Epub 2016 Oct 24.

PMID:
27778099
17.

Apathy in Mild Parkinson's Disease: Neuropsychological and Neuroimaging Evidence.

Alzahrani H, Antonini A, Venneri A.

J Parkinsons Dis. 2016 Oct 19;6(4):821-832.

PMID:
27567885
18.

PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach.

D'Arcangelo D, Facchiano F, Nassa G, Stancato A, Antonini A, Rossi S, Senatore C, Cordella M, Tabolacci C, Salvati A, Tarallo R, Weisz A, Facchiano AM, Facchiano A.

Oncotarget. 2016 Nov 22;7(47):77257-77275. doi: 10.18632/oncotarget.12629.

19.

Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.

Nigro S, Arabia G, Antonini A, Weis L, Marcante A, Tessitore A, Cirillo M, Tedeschi G, Zanigni S, Calandra-Buonaura G, Tonon C, Pezzoli G, Cilia R, Zappia M, Nicoletti A, Cicero CE, Tinazzi M, Tocco P, Cardobi N, Quattrone A.

Eur Radiol. 2016 Oct 19. [Epub ahead of print]

PMID:
27761709
20.

Anatomical and functional correlates of persistent pain in Parkinson's disease.

Polli A, Weis L, Biundo R, Thacker M, Turolla A, Koutsikos K, Chaudhuri KR, Antonini A.

Mov Disord. 2016 Dec;31(12):1854-1864. doi: 10.1002/mds.26826. Epub 2016 Oct 5.

PMID:
27704616

Supplemental Content

Loading ...
Support Center